Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123288) titled 'Establishment of a multimodal assessment system and predictive model for the efficacy of immune combination chemotherapy in advanced elderly non-small cell lung cancer with negative driver genes based on artificial intelligence' on April 23.

Study Type: Observational study

Study Design: Diagnostic test for accuracy

Primary Sponsor: Beijing Hospital

Condition: lung cancer

Recruitment Status: Recruiting

Phase: 2

Date of First Enrollment: 2026-04-30

Target Sample Size: Case group:460;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=320092

Disclaimer: Cur...